Validation of the novel Eosinophilic Esophagitis Symptom Questionnaire
The EoE-SQ showed good reliability, construct validity, and responsiveness for the assessment of EoE symptoms beyond dysphagia and can be used in combination with existing patient-reported outcome questionnaires to evaluate the full breadth of symptoms experienced by adult and adolescent patients with EoE.
Authors
- Siddhesh Kamat (ORCID: https://orcid.org/0000-0001-5205-9184)
- Sarette T. Tilton
- Jonathan M. Spergel (ORCID: https://orcid.org/0000-0002-4658-5353)
- Andrew Yaworsky (ORCID: https://orcid.org/0000-0003-3532-0795)
- Eilish McCann (ORCID: https://orcid.org/0000-0001-7156-9390)
- Xian Sun
- Mirna Chehade
Institutions
- Regeneron (United States) (US)
- Sanofi (France) (FR)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1016/j.jacig.2025.100554
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Regeneron Pharmaceuticals